Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Venlafaxine Hydrochloride Sustained-Release Capsules

Approval Number

国药准字H20223057

Company湖南洞庭药业股份有限公司

Registration Date

January 30, 2022

Drug Information

Generic Name

盐酸文拉法辛缓释胶囊

Dosage Form

胶囊剂

Strength

150mg（按C17H27NO2计）

Drug Type

化学药品

Registration Date

January 30, 2022

Company Information

Applicant Company

Company Name湖南洞庭药业股份有限公司

Company Address

湖南省常德经济技术开发区德山街道办事处陈家岗社区东沿路16号（常德市德山东沿路16号）

Manufacturing Company

Company Name湖南洞庭药业股份有限公司

Company Address

湖南省常德经济技术开发区德山大道 375号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy